Position in PGEN
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$66,041
-$5,290 QoQ
Shares Held
17,065
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allegheny Financial Group holds $1,531,910 across 6 Biotechnology names. PGEN ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,018 | $901,117 | |
| 2 | INSM |
INSMED Inc
|
1,479 | $241,846 | |
| 3 | ANNX |
Annexon, Inc.
|
42,900 | $237,666 | |
| 4 | PGEN |
Precigen, Inc.
This page
|
17,065 | $66,041 | |
| 5 | TSHA |
Taysha Gene Therapies, Inc.
|
12,000 | $53,640 | |
| 6 | LCTX |
Lineage Cell Therapeutics, Inc.
|
20,000 | $31,600 |
All Filings in PGEN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,041 | 17,065 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $71,331 | 17,065 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $56,143 | 17,065 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $76,864 | 54,130 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $80,653 | 54,130 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $60,625 | 54,130 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||